Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2252-2260

  Zhu, Hui ^a   Liu, Kechang ^a   Cerny, Jan ^a   Imoto, Taiji ^b   Moudgil, Kamal D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SOJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LYSOZYME; PROTEINASE;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE; THYMUS;

EID: 23444450284     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2252     Document Type: Article

References (60)

1. Gammon, G., and E. Sercarz. 1989. How some T cells escape tolerance induction. Nature 342: 183-185.
2. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11: 729-766.
3. Moudgil, K. D., and E. E. Sercarz. 1993. Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homologue, mouse lysozyme: implications in shaping of the T cell repertoire and autoimmunity. J. Exp. Med. 178: 2131-2138.
4. Sinha, P., H. H. Chi, H. R. Kim, B. E. Clausen, B. Pederson, E. E. Sercarz, I. Forster, and K. D. Moudgil. 2004. Mouse lysozyme-M knockout mice reveal how the self determinant hierarchy shapes the T cell repertoire against this circulating self antigen in wild-type mice. J. Immunol. 173: 1763-1771.
5. Benichou, G., P. A. Takizawa, P. T. Ho, C. C. Killion, C. A. Olson, M. McMillan, and E. E. Sercarz. 1990. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J. Exp. Med. 172: 1341-1346.
6. Anderton, S. M., N. J. Viner, P. Matharu, P. A. Lowrey, and D. C. Wraith. 2002. Influence of a dominant cryptic epitope on autoimmune T cell tolerance. Nat. Immunol. 3: 175-181.
7. Agrawal, B., M. Manickasundari, E. Fraga, and B. Singh. 1991. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice. J. Immunol. 147: 383-390.
8. Mamula, M. J. 1993. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J. Exp. Med. 177: 567-571.
9. Lehmann, P. V., T. Forsthuber, A. Miller, and E. E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155-157.
10. Raju, R., E. Marietta, J. Vinasco, B. M. Conti-Fine, A. J. Infante, and C. S. David. 2002. Cryptic determinants and promiscuous sequences on human acetylcholine receptor: HLA-dependent dichotomy in T-cell function. Hum. Immunol. 63: 237-247.
11. Fairchild, P. J. 1999. Reversal of immunodominance among autoantigenic T-cell epitopes. Autoimmunity 30: 209-221.
12. Cibotti, R., J. M. Kanellopoulos, J. P. Cabaniols, O. Halle-Panenko, K. Kosmatopoulos, E. Sercarz, and P. Kourilsky. 1992. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc. Natl. Acad. Sci. USA 89: 416-420.
13. Targoni, O. S., and P. V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187: 2055-2063.
14. 2-microglobulin to class II-restricted T cells leads to self-tolerance. J. Immunol. 154: 545-554.
15. Moudgil, K. D., S. Southwood, A. Ametani, K. Kim, A. Sette, and E. E. Sercarz. 1999. The self-directed T cell repertoire against mouse lysozyme reflects the influence of the hierarchy of its own determinants and can be engaged by a foreign lysozyme. J. Immunol. 163: 4232-4237.
16. Lipham, W. J., T. M. Redmond, H. Takahashi, J. A. Berzofsky, B. Wiggert, G. J. Chader, and I. Gery. 1991. Recognition of peptides that are immunopathogenic but cryptic: mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. J. Immunol. 146: 3757-3762.
17. Yan, J., and M. J. Mamula. 2002. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J. Immunol. 168: 3188-3194.
18. Moudgil, K. D., and E. E. Sercarz. 1994. The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer. Clin. Immunol. Immunopathol. 73: 283-289.
19. Lanzavecchia, A. 1995. How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181: 1945-1948.
20. Vanderlugt, C. L., and S. D. Miller. 2002. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2: 85-95.
21. Singh, R. R., V. Kumar, F. M. Ebling, S. Southwood, A. Sette, E. E. Sercarz, and B. H. Hahn. 1995. T cell determinants from autoantibodies to DNA can up-regulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181: 2017-2027.
22. Moudgil, K. D., E. E. Sercarz, and I. S. Grewal. 1998. Modulation of the immunogenicity of antigenic determinants by their flanking residues. Immunol. Today 19: 217-220.
23. Simitsek, P. D., D. G. Campbell, A. Lanzavecchia, N. Fairweather, and C. Watts. 1995. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med. 181: 1957-1963.
24. Salemi, S., A. P. Caporossi, L. Boffa, M. G. Longobardi, and V. Barnaba. 1995. HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181: 2253-2257.
25. Thatcher, T. H., D. P. O'Brien, S. Altuwaijri, and R. K. Barth. 2000. Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope. Immunology 99: 235-242.
26. Blum, J. S., C. Ma, and S. Kovats. 1997. Antigen-presenting cells and the selection of immunodominant epitopes. Crit. Rev. Immunol. 17: 411-417.
27. Nanda, N. K., and A. J. Sant. 2000. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192: 781-788.
28. Brett, S. J., K. B. Cease, and J. A. Berzofsky. 1988. Influences of antigen processing on the expression of the T cell repertoire: evidence for MHC-specific hindering structures on the products of processing. J. Exp. Med. 168: 357-373.
29. Boisgerault, F., N. G. Anosova, R. C. Tam, B. M. Illigens, E. V. Fedoseyeva, and G. Benichou. 2000. Induction of T-cell response to cryptic MHC determinants during allograft rejection. Hum. Immunol. 61: 1352-1362.
30. Moudgil, K. D., and E. E. Sercarz. 1994. Can antitumor immune responses discriminate between self and nonself? Immunol. Today 15: 353-355.
31. Disis, M. L., T. A. Gooley, K. Rinn, D. Davis, M. Piepkorn, M. A. Cheever, K. L. Knutson, and K. Schiffman. 2002. Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines. J. Clin. Oncol. 20: 2624-2632.
32. Scardino, A., D. A. Gross, P. Alves, J. L. Schultze, S. Graff-Dubois, O. Faure, S. Tourdot, S. Chouaib, L. M. Nadler, F. A. Lemonnier, et al. 2002. HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy. J. Immunol. 168: 5900-5906.
33. Docherty, K., and D. F. Steiner. 1982. Post-translational proteolysis in polypeptide hormone biosynthesis. Annu. Rev. Physiol. 44: 625-638.
34. Burger, E. 1988. Peptide hormones and neuropeptides: proteolytic processing of the precursor regulatory peptides. Arzneimittelforschung 38: 754-761.
35. Thorne, B. A., and G. Thomas. 1990. An in vivo characterization of the cleavage site specificity of the insulin cell prohormone processing enzymes. J. Biol. Chem. 265: 8436-8443.
36. Krieger, T. J., L. Mende-Mueller, and V. Y. Hook. 1992. Prohormone thiol protease and enkephalin precursor processing: cleavage at dibasic and monobasic sites. J. Neurochem. 59: 26-31.
37. Mine, S., S. Tate, T. Ueda, M. Kainosho, and T. Imoto. 1999. Analysis of the relationship between enzyme activity and its internal motion using nuclear magnetic resonance: 15N relaxation studies of wild-type and mutant lysozyme. J. Mol. Biol. 286: 1547-1565.
38. Osserman, E. F., and D. P. Lawlor. 1966. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J. Exp. Med. 124: 921-952.
39. Obita, T., T. Ueda, and T. Imoto. 2003. Solution structure and activity of mouse lysozyme M. Cell Mol Life Sci. 60: 176-184.
40. Harding, C. V. 1997. Antigen processing and presentation. In Current Protocols in Immunology. A. M. K. J. E. Coligan, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, Hoboken, pp. 16.0.1.-16.0.20.
41. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3: 645-649.
42. Viner, N. J., C. A. Nelson, B. Deck, and E. R. Unanue. 1996. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156: 2365-2368.
43. Vignali, D. A., R. G. Urban, R. M. Chicz, and J. L. Strominger. 1993. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 23: 1602-1607.
44. Kim, B. S., and Y. S. Jang. 1992. Constraints in antigen processing result in unresponsiveness to a T cell epitope of hen egg lysozyme in C57BL/6 mice. Eur. J. Immunol. 22: 775-782.
45. Lo-Man, R., P. Martineau, B. Manoury-Schwartz, M. Hofnung, and C. Leclerc. 1996. Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein. Int. Immunol. 8: 1245-1255.
46. Carson, R. T., K. M. Vignali, D. L. Woodland, and D. A. Vignali. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7: 387-399.
47. Rudensky, A., P. Preston-Hurlburt, B. K. al-Ramadi, J. Rothbard, and C. A. Janeway, Jr. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359: 429-431.
48. Schneider, S. C., J. Ohmen, L. Fosdick, B. Gladstone, J. Guo, A. Ametani, E. E. Sercarz, and H. Deng. 2000. Cutting edge: introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display. J. Immunol. 165: 20-23.
49. Seidah, N. G., and M. Chretien. 1997. Eukaryotic protein processing: endoproteolysis of precursor proteins. Curr. Opin. Biotechnol. 8: 602-607.
50. Steiner, D. F. 1998. The proprotein convertases. Curr. Opin. Chem. Biol. 2: 31-39.
51. Khatib, A. M., G. Siegfried, M. Chretien, P. Metrakos, and N. G. Seidah. 2002. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am. J. Pathol. 160: 1921-1935.
52. Bosshart, H., J. Humphrey, E. Deignan, J. Davidson, J. Drazba, L. Yuan, V. Oorschot, P. J. Peters, and J. S. Bonifacino. 1994. The cytoplasmic domain mediates localization of furin to the rrans-Golgi network en route to the endosomal/lysosomal system. J. Cell Biol. 126: 1157-1172.
53. Teuchert, M., W. Schafer, S. Berghofer, B. Hoflack, H. D. Klenk, and W. Garten. 1999. Sorting of furin at the rrans-Golgi network: interaction of the cytoplasmic tail sorting signals with AP-1 Golgi-specific assembly proteins. J. Biol. Chem. 274: 8199-8207.
54. Thomas, G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3: 753-766.
55. Schapiro, F. B., T. T. Soe, W. G. Mallet, and F. R. Maxfield. 2004. Role of cytoplasmic domain serines in intracellular trafficking of furin. Mol. Biol. Cell 15: 2884-2894.
56. Wolf, P. R., S. Tourne, T. Miyazaki, C. Benoist, D. Mathis, and H. L. Ploegh. 1998. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed. Eur. J. Immunol. 28: 2605-2618.
57. Ramachandra, L., S. Kovats, S. Eastman, and A. Y. Rudensky. 1996. Variation in HLA-DM expression influences conversion of MHC class II αβ:class II-associated invariant chain peptide complexes to mature peptide-bound class II αβ dimers in a normal B cell line. J. Immunol. 156: 2196-2204.
58. Blanchette, F., P. Rudd, F. Grondin, L. Attisano, and C. M. Dubois. 2001. Involvement of Smads in TGF/β1-induced furin (fur) transcription. J. Cell. Physiol. 188: 264-273.
59. Drakesmith, H., D. O'Neil, S. C. Schneider, M. Binks, P. Medd, E. Sercarz, P. Beverley, and B. Chain. 1998. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen. Proc. Natl. Acad. Sci. USA 95: 14903-14908.
60. Durai, M., H. R. Kim, and K. D. Moudgil. 2004. The regulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis. J. Immunol. 173: 181-188.